Human papillomavirus vaccine for cervical cancer prevention in India: new improvement and way forward

Meenakshi Sharma; Ekjot Kaur; Renu Sandhu; Samandeep Kaur

doi:10.18203/2394-6040.ijcmph20243322

Authors

Meenakshi Sharma Institute of Nursing University Regional Centre, Goindwal Sahib, Baba Farid University of Health Sciences, Faridkot, Punjab, India
Ekjot Kaur Institute of Nursing University Regional Centre, Goindwal Sahib, Baba Farid University of Health Sciences, Faridkot, Punjab, India
Renu Sandhu University College of Nursing, Baba Farid University of Health Sciences, Faridkot, Punjab, India
Samandeep Kaur University College of Nursing, Baba Farid University of Health Sciences, Faridkot, Punjab, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20243322

Keywords:

Cervical cancer, Cervarix, Cervavac, Gardasil, Human papilloma virus

Abstract

Cervical cancer is the malignant abnormal changes in the tissues of cervix mostly transmitted through the human papilloma virus. Prophylactic vaccination against HPV is effective strategy to prevent cervical cancer. India has access to two types of vaccines that are licensed worldwide, the bivalent cervarix and the quadrivalent Gardasil. The drug controller general of India has authorized “CERVAVAC” a new HPV vaccination that is less expensive and is being offered in India as a single dose for females between the ages of 9 and 19 years. The government said in February 2024 that girls between the ages of 9 and 14 will receive the HPV vaccine as part of universal immunization programme. There are significant obstacles to vaccination implementation in India like lack of epidemiological evidences for illness prioritization, vaccine duration, parental attitude and vaccine acceptance. The WHO's goal of eradicating cervical cancer by 2030 depends on implementing socially and culturally relevant public awareness campaigns after educational initiatives for healthcare professionals.

Metrics

Metrics Loading ...

References

Cervical cancer. Available at: https://www.who.int/news-room. Accessed on. 22 June 2024.

WHO. Comprehensive cervical cancer control. Geneva. 2014;366-78.

Cervical cancer profile. 2021;(2020):2021.

What Is Cervical Cancer? Cancer Research UK. Available at: https://www.cancerresearchuk.org. Accessed on 12 July 2024.

Anatomy of the uterine cervix and the transformation zone - Colposcopy and Treatment of Cervical Precancer - NCBI Bookshelf. Available at: https://www.ncbi.nlm.nih.gov/books. Accessed on 16 July 2024.

What is cervical cancer?Types of Cervical Cancer | American Cancer Society. Available at: https://www.cancer.org. Accessed on 9 July 2024.

MOH, WHO. Facts Sheet on Cervical Cancer. 2023. Available from: www.moh.gov.jm. Accessed on 19 June 2024.

Stefan DC, Dangou JM, Barango P, Mahamadou ID, Kapambwe S. Targeting elimination of cervical cancer by 2030: a baseline assessment in six African countries—part II. Cancer Medical Science. 2022;1:16.

Bhatla N, Meena J, Kumari S, Banerjee D, Singh P, Natarajan J. Cervical cancer prevention efforts in India. Indian J Gynecol Oncol. 2021;19(3):234.

Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012;33(1):7–12.

Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, Koutsky LA. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006;354(25):2645-54.

IAP. ACVIP. Available at: https://acvip.org/parents/columns/cervical-cancer. Accessed on 17 July 2024.

Stanley M. Human papilloma virus vaccines. Med Women. 2015;2:271–89.

Khoo F. Cervical cancer and screening. All about eve your women’s heal quest answered. 2022;2:65–70.

Mehrotra R, Yadav K. Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management. Indian J Gynecol Oncol. 2022;20(1):1–8.

IAP. ACVIP. Available at: https://acvip.org/parents/columns/cervical. Accessed on 5 July 2024.

Ahuja M, Sharma P SA. Short communication universal cervical cancer immunization : India Ready for a Quantum. 2023;10–2.

WHO. Weekly epidemiological record: Human papillomavirus vaccines: WHO position paper (2022 Update). Wkly Epidemiol Rec. 2022;97(50):645672.

WHO updates recommendations on HPV vaccination schedule. Available at: https://www.who.int/news/item. Accessed on 12 July 2024.

World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva. 2020:4;1-56 .

Harlfinger J, Sommer I, Gartlehner G. WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention. Gesundheitswesen. 2023;85:630–4.

HPV Vaccination in India. New Progress and the way forward Rajiv Gandhi Cancer Institute and Research Centre. Available at: https://www.rgcirc.org/blog/hpv. Accessed on 22 July 2024.

Adedimeji A, Ajeh R, Pierz A, Nkeng R, Ndenkeh JJ, Fuhngwa N, et al. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Women Health. 2021;21(1):1–14.

Ceravac - India's First HPV Vaccine for Cervical Cancer. Available at: https://www.medanta.org/ patient-education-blog/recent-update-ceravac-indias-first-hpv-vaccine-for-cervical-cancer. Accessed on 16 March 2024.

Salute to the Indian Government’s initiative in promoting cervical vaccine. Available at: https://continentalhospitals.com/blog. Accessed on 8 July 2024.

National technical advisory group on immunization. 17th National technical advisory group on Immunization (NTAGI) Meeting. 2022; Available at: https://main.mohfw.gov.in/sites. 8 June 2022.

Health Ministry yet to take a call on beginning HPV vaccination campaign for adolescent girls. The Hindu. Available at: https://www.thehindu.com/sci-tech/health/health. Accessed on 17 July 2024.

Kumari P, Kumari S, Rani J, Abhilashi K, Sinha S, Pankaj S, et al. HPV vaccination program: Hurdles and challenges in a tertiary care center! J Indira Gandhi Inst Med Sci. 2021;7(2):114.